2019 annual financial data
ProQR Therapeutics 2019 Net margin
Direct answer
Net margin was -2,935.64%.
Operating income was -57,445,000 EUR and net income was -56,746,000 EUR.
Operating cash flow was -43,970,000 EUR.
Get free ProQR Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 1,933,000 EUR
- Operating income
- -57,445,000 EUR
- Net income
- -56,746,000 EUR
- Operating cash flow
- -43,970,000 EUR